Table of Content

1 Report Overview
1.1 Genetic Engineering Drug Definition
1.2 Market by Type
1.2.1 Global Genetic Engineering Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Monoclonal Antibody
1.2.3 Recombinant Human Erythropoietin
1.2.4 Recombinant Human Interferon
1.2.5 Recombinant Human Growth Hormone
1.2.6 Recombinant Human Insulin
1.3 Market Segment by Application
1.3.1 Global Genetic Engineering Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Medicine
1.3.3 Research
1.3.4 Industrial
1.3.5 Agriculture
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Genetic Engineering Drug Sales
2.1 Global Genetic Engineering Drug Revenue Estimates and Forecasts 2018-2034
2.2 Global Genetic Engineering Drug Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Genetic Engineering Drug Revenue by Region
2.3.1 Global Genetic Engineering Drug Revenue by Region (2018-2024)
2.3.2 Global Genetic Engineering Drug Revenue by Region (2024-2034)
2.4 Global Genetic Engineering Drug Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Genetic Engineering Drug Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Genetic Engineering Drug Sales Quantity by Region
2.6.1 Global Genetic Engineering Drug Sales Quantity by Region (2018-2024)
2.6.2 Global Genetic Engineering Drug Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Genetic Engineering Drug Sales Quantity by Manufacturers
3.1.1 Global Genetic Engineering Drug Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Genetic Engineering Drug Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Genetic Engineering Drug Sales in 2022
3.2 Global Genetic Engineering Drug Revenue by Manufacturers
3.2.1 Global Genetic Engineering Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Genetic Engineering Drug Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Genetic Engineering Drug Revenue in 2022
3.3 Global Genetic Engineering Drug Sales Price by Manufacturers
3.4 Global Key Players of Genetic Engineering Drug, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Genetic Engineering Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Genetic Engineering Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Genetic Engineering Drug, Product Offered and Application
3.8 Global Key Manufacturers of Genetic Engineering Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Genetic Engineering Drug Sales Quantity by Type
4.1.1 Global Genetic Engineering Drug Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Genetic Engineering Drug Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Genetic Engineering Drug Sales Quantity Market Share by Type (2018-2034)
4.2 Global Genetic Engineering Drug Revenue by Type
4.2.1 Global Genetic Engineering Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Genetic Engineering Drug Forecasted Revenue by Type (2024-2034)
4.2.3 Global Genetic Engineering Drug Revenue Market Share by Type (2018-2034)
4.3 Global Genetic Engineering Drug Price by Type
4.3.1 Global Genetic Engineering Drug Price by Type (2018-2024)
4.3.2 Global Genetic Engineering Drug Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Genetic Engineering Drug Sales Quantity by Application
5.1.1 Global Genetic Engineering Drug Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Genetic Engineering Drug Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Genetic Engineering Drug Sales Quantity Market Share by Application (2018-2034)
5.2 Global Genetic Engineering Drug Revenue by Application
5.2.1 Global Genetic Engineering Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Genetic Engineering Drug Forecasted Revenue by Application (2024-2034)
5.2.3 Global Genetic Engineering Drug Revenue Market Share by Application (2018-2034)
5.3 Global Genetic Engineering Drug Price by Application
5.3.1 Global Genetic Engineering Drug Price by Application (2018-2024)
5.3.2 Global Genetic Engineering Drug Price Forecast by Application (2024-2034)
6 North America
6.1 North America Genetic Engineering Drug Sales by Company
6.1.1 North America Genetic Engineering Drug Revenue by Company (2018-2024)
6.1.2 North America Genetic Engineering Drug Sales Quantity by Company (2018-2024)
6.2 North America Genetic Engineering Drug Market Size by Type
6.2.1 North America Genetic Engineering Drug Sales Quantity by Type (2018-2034)
6.2.2 North America Genetic Engineering Drug Revenue by Type (2018-2034)
6.3 North America Genetic Engineering Drug Market Size by Application
6.3.1 North America Genetic Engineering Drug Sales Quantity by Application (2018-2034)
6.3.2 North America Genetic Engineering Drug Revenue by Application (2018-2034)
6.4 North America Genetic Engineering Drug Market Size by Country
6.4.1 North America Genetic Engineering Drug Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Genetic Engineering Drug Revenue by Country (2018-2034)
6.4.3 North America Genetic Engineering Drug Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Genetic Engineering Drug Sales by Company
7.1.1 Europe Genetic Engineering Drug Sales Quantity by Company (2018-2024)
7.1.2 Europe Genetic Engineering Drug Revenue by Company (2018-2024)
7.2 Europe Genetic Engineering Drug Market Size by Type
7.2.1 Europe Genetic Engineering Drug Sales Quantity by Type (2018-2034)
7.2.2 Europe Genetic Engineering Drug Revenue by Type (2018-2034)
7.3 Europe Genetic Engineering Drug Market Size by Application
7.3.1 Europe Genetic Engineering Drug Sales Quantity by Application (2018-2034)
7.3.2 Europe Genetic Engineering Drug Revenue by Application (2018-2034)
7.4 Europe Genetic Engineering Drug Market Size by Country
7.4.1 Europe Genetic Engineering Drug Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Genetic Engineering Drug Revenue by Country (2018-2034)
7.4.3 Europe Genetic Engineering Drug Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Genetic Engineering Drug Sales by Company
8.1.1 China Genetic Engineering Drug Sales Quantity by Company (2018-2024)
8.1.2 China Genetic Engineering Drug Revenue by Company (2018-2024)
8.2 China Genetic Engineering Drug Market Size by Type
8.2.1 China Genetic Engineering Drug Sales Quantity by Type (2018-2034)
8.2.2 China Genetic Engineering Drug Revenue by Type (2018-2034)
8.3 China Genetic Engineering Drug Market Size by Application
8.3.1 China Genetic Engineering Drug Sales Quantity by Application (2018-2034)
8.3.2 China Genetic Engineering Drug Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Genetic Engineering Drug Sales by Company
9.1.1 APAC Genetic Engineering Drug Sales Quantity by Company (2018-2024)
9.1.2 APAC Genetic Engineering Drug Revenue by Company (2018-2024)
9.2 APAC Genetic Engineering Drug Market Size by Type
9.2.1 APAC Genetic Engineering Drug Sales Quantity by Type (2018-2034)
9.2.2 APAC Genetic Engineering Drug Revenue by Type (2018-2034)
9.3 APAC Genetic Engineering Drug Market Size by Application
9.3.1 APAC Genetic Engineering Drug Sales Quantity by Application (2018-2034)
9.3.2 APAC Genetic Engineering Drug Revenue by Application (2018-2034)
9.4 APAC Genetic Engineering Drug Market Size by Region
9.4.1 APAC Genetic Engineering Drug Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Genetic Engineering Drug Revenue by Region (2018-2034)
9.4.3 APAC Genetic Engineering Drug Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Genetic Engineering Drug Sales by Company
10.1.1 Middle East, Africa and Latin America Genetic Engineering Drug Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Genetic Engineering Drug Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Genetic Engineering Drug Market Size by Type
10.2.1 Middle East, Africa and Latin America Genetic Engineering Drug Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Genetic Engineering Drug Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Genetic Engineering Drug Market Size by Application
10.3.1 Middle East, Africa and Latin America Genetic Engineering Drug Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Genetic Engineering Drug Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Genetic Engineering Drug Market Size by Country
10.4.1 Middle East, Africa and Latin America Genetic Engineering Drug Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Genetic Engineering Drug Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Genetic Engineering Drug Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Shanghai Lansheng Guojian Pharmaceutical
11.1.1 Shanghai Lansheng Guojian Pharmaceutical Company Information
11.1.2 Shanghai Lansheng Guojian Pharmaceutical Overview
11.1.3 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Products and Services
11.1.5 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug SWOT Analysis
11.1.6 Shanghai Lansheng Guojian Pharmaceutical Recent Developments
11.2 Biotech Pharmaceutical
11.2.1 Biotech Pharmaceutical Company Information
11.2.2 Biotech Pharmaceutical Overview
11.2.3 Biotech Pharmaceutical Genetic Engineering Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Biotech Pharmaceutical Genetic Engineering Drug Products and Services
11.2.5 Biotech Pharmaceutical Genetic Engineering Drug SWOT Analysis
11.2.6 Biotech Pharmaceutical Recent Developments
11.3 Anhui Anke Biotechnology
11.3.1 Anhui Anke Biotechnology Company Information
11.3.2 Anhui Anke Biotechnology Overview
11.3.3 Anhui Anke Biotechnology Genetic Engineering Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Anhui Anke Biotechnology Genetic Engineering Drug Products and Services
11.3.5 Anhui Anke Biotechnology Genetic Engineering Drug SWOT Analysis
11.3.6 Anhui Anke Biotechnology Recent Developments
11.4 GeneScience Pharmaceuticals
11.4.1 GeneScience Pharmaceuticals Company Information
11.4.2 GeneScience Pharmaceuticals Overview
11.4.3 GeneScience Pharmaceuticals Genetic Engineering Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 GeneScience Pharmaceuticals Genetic Engineering Drug Products and Services
11.4.5 GeneScience Pharmaceuticals Genetic Engineering Drug SWOT Analysis
11.4.6 GeneScience Pharmaceuticals Recent Developments
11.5 Beijing SL Pharmaceutical
11.5.1 Beijing SL Pharmaceutical Company Information
11.5.2 Beijing SL Pharmaceutical Overview
11.5.3 Beijing SL Pharmaceutical Genetic Engineering Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Beijing SL Pharmaceutical Genetic Engineering Drug Products and Services
11.5.5 Beijing SL Pharmaceutical Genetic Engineering Drug SWOT Analysis
11.5.6 Beijing SL Pharmaceutical Recent Developments
11.6 Jiangsu Sihuan Bioengineering
11.6.1 Jiangsu Sihuan Bioengineering Company Information
11.6.2 Jiangsu Sihuan Bioengineering Overview
11.6.3 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Products and Services
11.6.5 Jiangsu Sihuan Bioengineering Genetic Engineering Drug SWOT Analysis
11.6.6 Jiangsu Sihuan Bioengineering Recent Developments
11.7 Shenzhen Neptunus Interlong Bio-Technique
11.7.1 Shenzhen Neptunus Interlong Bio-Technique Company Information
11.7.2 Shenzhen Neptunus Interlong Bio-Technique Overview
11.7.3 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Products and Services
11.7.5 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug SWOT Analysis
11.7.6 Shenzhen Neptunus Interlong Bio-Technique Recent Developments
11.8 3SBio
11.8.1 3SBio Company Information
11.8.2 3SBio Overview
11.8.3 3SBio Genetic Engineering Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 3SBio Genetic Engineering Drug Products and Services
11.8.5 3SBio Genetic Engineering Drug SWOT Analysis
11.8.6 3SBio Recent Developments
11.9 Tonghua Dongbao Pharmaceutical
11.9.1 Tonghua Dongbao Pharmaceutical Company Information
11.9.2 Tonghua Dongbao Pharmaceutical Overview
11.9.3 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Products and Services
11.9.5 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug SWOT Analysis
11.9.6 Tonghua Dongbao Pharmaceutical Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Genetic Engineering Drug Value Chain Analysis
12.2 Genetic Engineering Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Genetic Engineering Drug Production Mode & Process
12.4 Genetic Engineering Drug Sales and Marketing
12.4.1 Genetic Engineering Drug Sales Channels
12.4.2 Genetic Engineering Drug Distributors
12.5 Genetic Engineering Drug Customers
13 Market Dynamics
13.1 Genetic Engineering Drug Industry Trends
13.2 Genetic Engineering Drug Market Drivers
13.3 Genetic Engineering Drug Market Challenges
13.4 Genetic Engineering Drug Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Genetic Engineering Drug Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Monoclonal Antibody
Table 3. Major Manufacturers of Recombinant Human Erythropoietin
Table 4. Major Manufacturers of Recombinant Human Interferon
Table 5. Major Manufacturers of Recombinant Human Growth Hormone
Table 6. Major Manufacturers of Recombinant Human Insulin
Table 7. Global Genetic Engineering Drug Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Genetic Engineering Drug Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 9. Global Genetic Engineering Drug Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Genetic Engineering Drug Revenue Market Share by Region (2018-2024)
Table 11. Global Genetic Engineering Drug Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Genetic Engineering Drug Revenue Market Share by Region (2024-2034)
Table 13. Global Genetic Engineering Drug Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 14. Global Genetic Engineering Drug Sales by Region (2018-2024) & (K Units)
Table 15. Global Genetic Engineering Drug Sales Market Share by Region (2018-2024)
Table 16. Global Genetic Engineering Drug Sales by Region (2024-2034) & (K Units)
Table 17. Global Genetic Engineering Drug Sales Market Share by Region (2024-2034)
Table 18. Global Genetic Engineering Drug Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 19. Global Genetic Engineering Drug Sales Quantity Share by Manufacturers (2018-2024)
Table 20. Global Genetic Engineering Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Genetic Engineering Drug Revenue Share by Manufacturers (2018-2024)
Table 22. Global Genetic Engineering Drug Price by Manufacturers 2018-2024 (USD/Unit)
Table 23. Global Key Players of Genetic Engineering Drug, Industry Ranking, 2021 VS 2022
Table 24. Global Genetic Engineering Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Genetic Engineering Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genetic Engineering Drug as of 2022)
Table 26. Global Key Manufacturers of Genetic Engineering Drug, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Genetic Engineering Drug, Product Offered and Application
Table 28. Global Key Manufacturers of Genetic Engineering Drug, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Genetic Engineering Drug Sales Quantity by Type (2018-2024) & (K Units)
Table 31. Global Genetic Engineering Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 32. Global Genetic Engineering Drug Sales Quantity Share by Type (2018-2024)
Table 33. Global Genetic Engineering Drug Sales Quantity Share by Type (2024-2034)
Table 34. Global Genetic Engineering Drug Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Genetic Engineering Drug Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Genetic Engineering Drug Revenue Share by Type (2018-2024)
Table 37. Global Genetic Engineering Drug Revenue Share by Type (2024-2034)
Table 38. Genetic Engineering Drug Price by Type (2018-2024) & (USD/Unit)
Table 39. Global Genetic Engineering Drug Price Forecast by Type (2024-2034) & (USD/Unit)
Table 40. Global Genetic Engineering Drug Sales Quantity by Application (2018-2024) & (K Units)
Table 41. Global Genetic Engineering Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 42. Global Genetic Engineering Drug Sales Quantity Share by Application (2018-2024)
Table 43. Global Genetic Engineering Drug Sales Quantity Share by Application (2024-2034)
Table 44. Global Genetic Engineering Drug Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Genetic Engineering Drug Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Genetic Engineering Drug Revenue Share by Application (2018-2024)
Table 47. Global Genetic Engineering Drug Revenue Share by Application (2024-2034)
Table 48. Genetic Engineering Drug Price by Application (2018-2024) & (USD/Unit)
Table 49. Global Genetic Engineering Drug Price Forecast by Application (2024-2034) & (USD/Unit)
Table 50. North America Genetic Engineering Drug Revenue by Company (2018-2024) & (US$ Million)
Table 51. North America Genetic Engineering Drug Sales Quantity by Company (2018-2024) & (K Units)
Table 52. North America Genetic Engineering Drug Sales Quantity by Type (2018-2024) & (K Units)
Table 53. North America Genetic Engineering Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 54. North America Genetic Engineering Drug Revenue by Type (2018-2024) & (US$ Million)
Table 55. North America Genetic Engineering Drug Revenue by Type (2024-2034) & (US$ Million)
Table 56. North America Genetic Engineering Drug Sales Quantity by Application (2018-2024) & (K Units)
Table 57. North America Genetic Engineering Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 58. North America Genetic Engineering Drug Revenue by Application (2018-2024) & (US$ Million)
Table 59. North America Genetic Engineering Drug Revenue by Application (2024-2034) & (US$ Million)
Table 60. North America Genetic Engineering Drug Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 61. North America Genetic Engineering Drug Revenue by Country (2018-2024) & (US$ Million)
Table 62. North America Genetic Engineering Drug Revenue by Country (2024-2034) & (US$ Million)
Table 63. North America Genetic Engineering Drug Sales Quantity by Country (2018-2024) & (K Units)
Table 64. North America Genetic Engineering Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 65. Europe Genetic Engineering Drug Sales Quantity by Company (2018-2024) & (K Units)
Table 66. Europe Genetic Engineering Drug Revenue by Company (2018-2024) & (US$ Million)
Table 67. Europe Genetic Engineering Drug Sales Quantity by Type (2018-2024) & (K Units)
Table 68. Europe Genetic Engineering Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 69. Europe Genetic Engineering Drug Revenue by Type (2018-2024) & (US$ Million)
Table 70. Europe Genetic Engineering Drug Revenue by Type (2024-2034) & (US$ Million)
Table 71. Europe Genetic Engineering Drug Sales Quantity by Application (2018-2024) & (K Units)
Table 72. Europe Genetic Engineering Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 73. Europe Genetic Engineering Drug Revenue by Application (2018-2024) & (US$ Million)
Table 74. Europe Genetic Engineering Drug Revenue by Application (2024-2034) & (US$ Million)
Table 75. Europe Genetic Engineering Drug Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 76. Europe Genetic Engineering Drug Revenue by Country (2018-2024) & (US$ Million)
Table 77. Europe Genetic Engineering Drug Revenue by Country (2024-2034) & (US$ Million)
Table 78. Europe Genetic Engineering Drug Sales Quantity by Country (2018-2024) & (K Units)
Table 79. Europe Genetic Engineering Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 80. China Genetic Engineering Drug Sales Quantity by Company (2018-2024) & (K Units)
Table 81. China Genetic Engineering Drug Revenue by Company (2018-2024) & (US$ Million)
Table 82. China Genetic Engineering Drug Sales Quantity by Type (2018-2024) & (K Units)
Table 83. China Genetic Engineering Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 84. China Genetic Engineering Drug Revenue by Type (2018-2024) & (US$ Million)
Table 85. China Genetic Engineering Drug Revenue by Type (2024-2034) & (US$ Million)
Table 86. China Genetic Engineering Drug Sales Quantity by Application (2018-2024) & (K Units)
Table 87. China Genetic Engineering Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 88. China Genetic Engineering Drug Revenue by Application (2018-2024) & (US$ Million)
Table 89. China Genetic Engineering Drug Revenue by Application (2024-2034) & (US$ Million)
Table 90. APAC Genetic Engineering Drug Sales Quantity by Company (2018-2024) & (K Units)
Table 91. APAC Genetic Engineering Drug Revenue by Company (2018-2024) & (US$ Million)
Table 92. APAC Genetic Engineering Drug Sales Quantity by Type (2018-2024) & (K Units)
Table 93. APAC Genetic Engineering Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 94. APAC Genetic Engineering Drug Revenue by Type (2018-2024) & (US$ Million)
Table 95. APAC Genetic Engineering Drug Revenue by Type (2024-2034) & (US$ Million)
Table 96. APAC Genetic Engineering Drug Sales Quantity by Application (2018-2024) & (K Units)
Table 97. APAC Genetic Engineering Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 98. APAC Genetic Engineering Drug Revenue by Application (2018-2024) & (US$ Million)
Table 99. APAC Genetic Engineering Drug Revenue by Application (2024-2034) & (US$ Million)
Table 100. APAC Genetic Engineering Drug Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 101. APAC Genetic Engineering Drug Revenue by Region (2018-2024) & (US$ Million)
Table 102. APAC Genetic Engineering Drug Revenue by Region (2024-2034) & (US$ Million)
Table 103. APAC Genetic Engineering Drug Sales Quantity by Region (2018-2024) & (K Units)
Table 104. APAC Genetic Engineering Drug Sales Quantity by Region (2024-2034) & (K Units)
Table 105. Middle East, Africa and Latin America Genetic Engineering Drug Sales Quantity by Company (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Genetic Engineering Drug Revenue by Company (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Genetic Engineering Drug Sales Quantity by Type (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Genetic Engineering Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 109. Middle East, Africa and Latin America Genetic Engineering Drug Revenue by Type (2018-2024) & (US$ Million)
Table 110. Middle East, Africa and Latin America Genetic Engineering Drug Revenue by Type (2024-2034) & (US$ Million)
Table 111. Middle East, Africa and Latin America Genetic Engineering Drug Sales Quantity by Application (2018-2024) & (K Units)
Table 112. Middle East, Africa and Latin America Genetic Engineering Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 113. Middle East, Africa and Latin America Genetic Engineering Drug Revenue by Application (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Genetic Engineering Drug Revenue by Application (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Genetic Engineering Drug Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 116. Middle East, Africa and Latin America Genetic Engineering Drug Revenue by Country (2018-2024) & (US$ Million)
Table 117. Middle East, Africa and Latin America Genetic Engineering Drug Revenue by Country (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Genetic Engineering Drug Sales Quantity by Country (2018-2024) & (K Units)
Table 119. Middle East, Africa and Latin America Genetic Engineering Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 120. Shanghai Lansheng Guojian Pharmaceutical Company Information
Table 121. Shanghai Lansheng Guojian Pharmaceutical Description and Overview
Table 122. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 123. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product and Services
Table 124. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug SWOT Analysis
Table 125. Shanghai Lansheng Guojian Pharmaceutical Recent Developments
Table 126. Biotech Pharmaceutical Company Information
Table 127. Biotech Pharmaceutical Description and Overview
Table 128. Biotech Pharmaceutical Genetic Engineering Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 129. Biotech Pharmaceutical Genetic Engineering Drug Product and Services
Table 130. Biotech Pharmaceutical Genetic Engineering Drug SWOT Analysis
Table 131. Biotech Pharmaceutical Recent Developments
Table 132. Anhui Anke Biotechnology Company Information
Table 133. Anhui Anke Biotechnology Description and Overview
Table 134. Anhui Anke Biotechnology Genetic Engineering Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 135. Anhui Anke Biotechnology Genetic Engineering Drug Product and Services
Table 136. Anhui Anke Biotechnology Genetic Engineering Drug SWOT Analysis
Table 137. Anhui Anke Biotechnology Recent Developments
Table 138. GeneScience Pharmaceuticals Company Information
Table 139. GeneScience Pharmaceuticals Description and Overview
Table 140. GeneScience Pharmaceuticals Genetic Engineering Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 141. GeneScience Pharmaceuticals Genetic Engineering Drug Product and Services
Table 142. GeneScience Pharmaceuticals Genetic Engineering Drug SWOT Analysis
Table 143. GeneScience Pharmaceuticals Recent Developments
Table 144. Beijing SL Pharmaceutical Company Information
Table 145. Beijing SL Pharmaceutical Description and Overview
Table 146. Beijing SL Pharmaceutical Genetic Engineering Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 147. Beijing SL Pharmaceutical Genetic Engineering Drug Product and Services
Table 148. Beijing SL Pharmaceutical Genetic Engineering Drug SWOT Analysis
Table 149. Beijing SL Pharmaceutical Recent Developments
Table 150. Jiangsu Sihuan Bioengineering Company Information
Table 151. Jiangsu Sihuan Bioengineering Description and Overview
Table 152. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 153. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product and Services
Table 154. Jiangsu Sihuan Bioengineering Genetic Engineering Drug SWOT Analysis
Table 155. Jiangsu Sihuan Bioengineering Recent Developments
Table 156. Shenzhen Neptunus Interlong Bio-Technique Company Information
Table 157. Shenzhen Neptunus Interlong Bio-Technique Description and Overview
Table 158. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 159. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product and Services
Table 160. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug SWOT Analysis
Table 161. Shenzhen Neptunus Interlong Bio-Technique Recent Developments
Table 162. 3SBio Company Information
Table 163. 3SBio Description and Overview
Table 164. 3SBio Genetic Engineering Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 165. 3SBio Genetic Engineering Drug Product and Services
Table 166. 3SBio Genetic Engineering Drug SWOT Analysis
Table 167. 3SBio Recent Developments
Table 168. Tonghua Dongbao Pharmaceutical Company Information
Table 169. Tonghua Dongbao Pharmaceutical Description and Overview
Table 170. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 171. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product and Services
Table 172. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug SWOT Analysis
Table 173. Tonghua Dongbao Pharmaceutical Recent Developments
Table 174. Key Raw Materials Lists
Table 175. Raw Materials Key Suppliers Lists
Table 176. Genetic Engineering Drug Distributors List
Table 177. Genetic Engineering Drug Customers List
Table 178. Genetic Engineering Drug Market Trends
Table 179. Genetic Engineering Drug Market Drivers
Table 180. Genetic Engineering Drug Market Challenges
Table 181. Genetic Engineering Drug Market Restraints
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Genetic Engineering Drug Product Picture
Figure 2. Global Genetic Engineering Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Genetic Engineering Drug Market Share by Type in 2022 & 2034
Figure 4. Monoclonal Antibody Product Picture
Figure 5. Recombinant Human Erythropoietin Product Picture
Figure 6. Recombinant Human Interferon Product Picture
Figure 7. Recombinant Human Growth Hormone Product Picture
Figure 8. Recombinant Human Insulin Product Picture
Figure 9. Global Genetic Engineering Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 10. Global Genetic Engineering Drug Market Share by Application in 2022 & 2034
Figure 11. Medicine
Figure 12. Research
Figure 13. Industrial
Figure 14. Agriculture
Figure 15. Other
Figure 16. Genetic Engineering Drug Report Years Considered
Figure 17. Global Genetic Engineering Drug Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 18. Global Genetic Engineering Drug Revenue 2018-2034 (US$ Million)
Figure 19. Global Genetic Engineering Drug Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 20. Global Genetic Engineering Drug Sales Quantity 2018-2034 (K Units)
Figure 21. Global Genetic Engineering Drug Sales Quantity Market Share by Region (2018-2024)
Figure 22. Global Genetic Engineering Drug Sales Quantity Market Share by Region (2024-2034)
Figure 23. North America Genetic Engineering Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. North America Genetic Engineering Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Europe Genetic Engineering Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. Europe Genetic Engineering Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 27. China Genetic Engineering Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 28. China Genetic Engineering Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 29. APAC Genetic Engineering Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 30. APAC Genetic Engineering Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 31. Middle East, Africa and Latin America Genetic Engineering Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 32. Middle East, Africa and Latin America Genetic Engineering Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 33. The Top 10 and Top 5 Players Market Share by Genetic Engineering Drug Sales Quantity in 2022
Figure 34. The Top 10 and Top 5 Players Market Share by Genetic Engineering Drug Revenue in 2022
Figure 35. Genetic Engineering Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 36. Global Genetic Engineering Drug Sales Quantity Market Share by Type (2018-2034)
Figure 37. Global Genetic Engineering Drug Revenue Market Share by Type (2018-2034)
Figure 38. Global Genetic Engineering Drug Sales Quantity Market Share by Application (2018-2034)
Figure 39. Global Genetic Engineering Drug Revenue Market Share by Application (2018-2034)
Figure 40. North America Genetic Engineering Drug Revenue Market Share by Company in 2022
Figure 41. North America Genetic Engineering Drug Sales Quantity Market Share by Company in 2022
Figure 42. North America Genetic Engineering Drug Sales Quantity Market Share by Type (2018-2034)
Figure 43. North America Genetic Engineering Drug Revenue Market Share by Type (2018-2034)
Figure 44. North America Genetic Engineering Drug Sales Quantity Market Share by Application (2018-2034)
Figure 45. North America Genetic Engineering Drug Revenue Market Share by Application (2018-2034)
Figure 46. North America Genetic Engineering Drug Revenue Share by Country (2018-2034)
Figure 47. North America Genetic Engineering Drug Sales Quantity Share by Country (2018-2034)
Figure 48. U.S. Genetic Engineering Drug Revenue (2018-2034) & (US$ Million)
Figure 49. Canada Genetic Engineering Drug Revenue (2018-2034) & (US$ Million)
Figure 50. Europe Genetic Engineering Drug Sales Quantity Market Share by Company in 2022
Figure 51. Europe Genetic Engineering Drug Revenue Market Share by Company in 2022
Figure 52. Europe Genetic Engineering Drug Sales Quantity Market Share by Type (2018-2034)
Figure 53. Europe Genetic Engineering Drug Revenue Market Share by Type (2018-2034)
Figure 54. Europe Genetic Engineering Drug Sales Quantity Market Share by Application (2018-2034)
Figure 55. Europe Genetic Engineering Drug Revenue Market Share by Application (2018-2034)
Figure 56. Europe Genetic Engineering Drug Revenue Share by Country (2018-2034)
Figure 57. Europe Genetic Engineering Drug Sales Quantity Share by Country (2018-2034)
Figure 58. Germany Genetic Engineering Drug Revenue (2018-2034) & (US$ Million)
Figure 59. France Genetic Engineering Drug Revenue (2018-2034) & (US$ Million)
Figure 60. U.K. Genetic Engineering Drug Revenue (2018-2034) & (US$ Million)
Figure 61. Italy Genetic Engineering Drug Revenue (2018-2034) & (US$ Million)
Figure 62. Russia Genetic Engineering Drug Revenue (2018-2034) & (US$ Million)
Figure 63. China Genetic Engineering Drug Sales Quantity Market Share by Company in 2022
Figure 64. China Genetic Engineering Drug Revenue Market Share by Company in 2022
Figure 65. China Genetic Engineering Drug Sales Quantity Market Share by Type (2018-2034)
Figure 66. China Genetic Engineering Drug Revenue Market Share by Type (2018-2034)
Figure 67. China Genetic Engineering Drug Sales Quantity Market Share by Application (2018-2034)
Figure 68. China Genetic Engineering Drug Revenue Market Share by Application (2018-2034)
Figure 69. APAC Genetic Engineering Drug Sales Quantity Market Share by Company in 2022
Figure 70. APAC Genetic Engineering Drug Revenue Market Share by Company in 2022
Figure 71. APAC Genetic Engineering Drug Sales Quantity Market Share by Type (2018-2034)
Figure 72. APAC Genetic Engineering Drug Revenue Market Share by Type (2018-2034)
Figure 73. APAC Genetic Engineering Drug Sales Quantity Market Share by Application (2018-2034)
Figure 74. APAC Genetic Engineering Drug Revenue Market Share by Application (2018-2034)
Figure 75. APAC Genetic Engineering Drug Revenue Share by Region (2018-2034)
Figure 76. APAC Genetic Engineering Drug Sales Quantity Share by Region (2018-2034)
Figure 77. Japan Genetic Engineering Drug Revenue (2018-2034) & (US$ Million)
Figure 78. South Korea Genetic Engineering Drug Revenue (2018-2034) & (US$ Million)
Figure 79. China Taiwan Genetic Engineering Drug Revenue (2018-2034) & (US$ Million)
Figure 80. Southeast Asia Genetic Engineering Drug Revenue (2018-2034) & (US$ Million)
Figure 81. India Genetic Engineering Drug Revenue (2018-2034) & (US$ Million)
Figure 82. Middle East, Africa and Latin America Genetic Engineering Drug Sales Quantity Market Share by Company in 2022
Figure 83. Middle East, Africa and Latin America Genetic Engineering Drug Revenue Market Share by Company in 2022
Figure 84. Middle East, Africa and Latin America Genetic Engineering Drug Sales Quantity Market Share by Type (2018-2034)
Figure 85. Middle East, Africa and Latin America Genetic Engineering Drug Revenue Market Share by Type (2018-2034)
Figure 86. Middle East, Africa and Latin America Genetic Engineering Drug Sales Quantity Market Share by Application (2018-2034)
Figure 87. Middle East, Africa and Latin America Genetic Engineering Drug Revenue Market Share by Application (2018-2034)
Figure 88. Middle East, Africa and Latin America Genetic Engineering Drug Sales Quantity Share by Country (2018-2034)
Figure 89. Middle East, Africa and Latin America Genetic Engineering Drug Revenue Share by Country (2018-2034)
Figure 90. Brazil Genetic Engineering Drug Revenue (2018-2034) & (US$ Million)
Figure 91. Mexico Genetic Engineering Drug Revenue (2018-2034) & (US$ Million)
Figure 92. Turkey Genetic Engineering Drug Revenue (2018-2034) & (US$ Million)
Figure 93. Israel Genetic Engineering Drug Revenue (2018-2034) & (US$ Million)
Figure 94. GCC Countries Genetic Engineering Drug Revenue (2018-2034) & (US$ Million)
Figure 95. Genetic Engineering Drug Value Chain
Figure 96. Genetic Engineering Drug Production Process
Figure 97. Channels of Distribution (Direct Vs Distribution)
Figure 98. Distributors Profiles
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed